Clinical Trials
5 trialsNCT04624204 2026-05-26
MK 7339-013
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT04948333 2026-03-18
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
Novartis
Phase 3 Completed
NCT06560632 2026-01-16
POLAR
Repare Therapeutics
Phase 1 Terminated
NCT04487236 2025-08-11
Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors
Suzhou Zanrong Pharma Limited
Phase 1 Completed
NCT06128148 2025-07-14
JYP0322
Guangzhou JOYO Pharma Co., Ltd
Phase 1 Recruiting